Another few key points 1) Exisiting sales backlog of $70m due starting next month 2) New low cost EV bus model already generating sales interest by clients who have short commute use-cases like airports etc 3) By setting up new plant in the US they are eligible for any grants from the Biden govt 4) If Pfizer and others do have a working vaccine, I expect travel and tourism numbers to spike owing to pent up demand 5) Very good chance they uplist to an American exchange next year ...